CN104840599A - Medicine for treating ankylosing spondylitis - Google Patents
Medicine for treating ankylosing spondylitis Download PDFInfo
- Publication number
- CN104840599A CN104840599A CN201510286495.3A CN201510286495A CN104840599A CN 104840599 A CN104840599 A CN 104840599A CN 201510286495 A CN201510286495 A CN 201510286495A CN 104840599 A CN104840599 A CN 104840599A
- Authority
- CN
- China
- Prior art keywords
- medicine
- radix
- medicines
- ankylosing spondylitis
- root
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 43
- 206010002556 Ankylosing Spondylitis Diseases 0.000 title claims abstract description 22
- 229940079593 drug Drugs 0.000 title claims abstract description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 10
- 210000000582 semen Anatomy 0.000 claims description 15
- 230000003203 everyday effect Effects 0.000 claims description 7
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 5
- 238000007598 dipping method Methods 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 238000010025 steaming Methods 0.000 claims description 4
- 210000003734 kidney Anatomy 0.000 abstract description 13
- 210000004185 liver Anatomy 0.000 abstract description 11
- 208000024891 symptom Diseases 0.000 abstract description 8
- 230000007812 deficiency Effects 0.000 abstract description 5
- 241000213006 Angelica dahurica Species 0.000 abstract description 2
- 235000013399 edible fruits Nutrition 0.000 abstract 3
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 2
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 2
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 235000011202 Angiopteris lygodiifolia Nutrition 0.000 abstract 1
- 244000306301 Caesalpinia sappan Species 0.000 abstract 1
- 235000015162 Caesalpinia sappan Nutrition 0.000 abstract 1
- 244000077995 Coix lacryma jobi Species 0.000 abstract 1
- 244000241463 Cullen corylifolium Species 0.000 abstract 1
- 241000110637 Cuscuta chinensis Species 0.000 abstract 1
- 241000723185 Cyathea Species 0.000 abstract 1
- 241000241550 Cyathula Species 0.000 abstract 1
- 241000123589 Dipsacus Species 0.000 abstract 1
- 244000286838 Eclipta prostrata Species 0.000 abstract 1
- 241000208688 Eucommia Species 0.000 abstract 1
- 235000018142 Hedysarum alpinum var americanum Nutrition 0.000 abstract 1
- 240000006461 Hedysarum alpinum var. americanum Species 0.000 abstract 1
- 244000018716 Impatiens biflora Species 0.000 abstract 1
- 235000015912 Impatiens biflora Nutrition 0.000 abstract 1
- 240000005779 Jasminum multiflorum Species 0.000 abstract 1
- 241000830535 Ligustrum lucidum Species 0.000 abstract 1
- 241000195954 Lycopodium clavatum Species 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 235000005155 Tanacetum balsamita Nutrition 0.000 abstract 1
- 241000316342 Taxillus Species 0.000 abstract 1
- 239000000853 adhesive Substances 0.000 abstract 1
- 230000001070 adhesive effect Effects 0.000 abstract 1
- 239000009910 sargent gloryvine Substances 0.000 abstract 1
- 230000017531 blood circulation Effects 0.000 description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 208000002193 Pain Diseases 0.000 description 11
- 201000010099 disease Diseases 0.000 description 10
- 230000001737 promoting effect Effects 0.000 description 10
- 210000003205 muscle Anatomy 0.000 description 9
- 210000000988 bone and bone Anatomy 0.000 description 7
- 230000008901 benefit Effects 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 230000004054 inflammatory process Effects 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 3
- 208000008035 Back Pain Diseases 0.000 description 3
- 208000037976 chronic inflammation Diseases 0.000 description 3
- 210000001624 hip Anatomy 0.000 description 3
- 102000004127 Cytokines Human genes 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 230000006020 chronic inflammation Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000003958 fumigation Methods 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 241000792859 Enema Species 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 108090001005 Interleukin-6 Proteins 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 206010058907 Spinal deformity Diseases 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 208000019065 cervical carcinoma Diseases 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 208000037893 chronic inflammatory disorder Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000009266 disease activity Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 239000007920 enema Substances 0.000 description 1
- 229940095399 enema Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000006749 inflammatory damage Effects 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000013160 medical therapy Methods 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 210000003131 sacroiliac joint Anatomy 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicine for treating ankylosing spondylitis. The medicine mainly comprises medicines for oral administration and medicines for external use, wherein the medicines for oral administration include 15g of Chinese dodder seed, 15g of fried himalayan teasel root, 10g of fried eucommia bark, 10g of prepared rhizome of adhesive rehmannia, 10g of common macrocarpium fruit, 15g of east Asian tree fern rhizome, 15g of Chinese taxillus twig, 15g of medicinal cyathula root, 10g of malaytea scurfpea fruit, 15g of cassia twig, 8g of glossy privet fruit, 8g of yerbadetajo herb, 15g of Chinese angelica, 15g of peach seed, 30g of white paeony root and 6g of liquorice root; one dose is taken each day and is decocted in water; the medicines for external use include 15g of incised notopterygium, 15g of cassia twig, 15g of stem of sargentgloryvine, 15g of common clubmoss herb, 15g of garden balsam stem, 8g of sappan wood, 10g of Chinese starjasmine stem and 30g of coix seed; patients lie supine on a fumigating bed, and the medicines for external use are added to water to be decocted for fumigating the patients. The medicine combines the interior and the exterior and treats both symptoms and root causes when being used for treating ankylosing spondylitis, and has obvious efficiency especially when being used for treating ankylosing spondylitis caused by deficiency of the liver and kidneys.
Description
Technical field
The present invention relates to technical field of Chinese medicines, specifically a kind of medicine for the treatment of ankylosing spondylitis.
Background technology
Ankylosing spondylitis is clinical common chronic inflammation disease, mainly to invade spinal column apophysis, sacroiliac joint, the other soft tissue of spinal column and joint, periphery for feature, its incidence of occult, patient engenders that lower back or sacroiliac have an intense pain more, alleviate after activity, the sustainable several months, wrong treatment or mistake are controlled and can be caused deformity of spine and tetanic pathological changes, have a strong impact on the quality of life of patient.Modern medical therapy, based on Drug therapys such as non-steroid antiinflammatory drugs, is intended to relief of symptoms, symptom management, prevents joint deformity.But the untoward reaction that for a long time existence of use is certain, especially gastrointestinal upset serious symptom is heavy then cause ulcerative hemorrhage, perforation, marrow suppression, abnormal liver function etc.
[1].Comparatively speaking, Enema compress opinion control and can learn from other's strong points to offset one's weaknesses, have rapid-action, untoward reaction is few, ask advantage and characteristics such as originally digging up the roots.
Summary of the invention
The object of the present invention is to provide a kind of medicine for the treatment of ankylosing spondylitis.Chinese medicine preparation of the present invention adopts for oral administration, stifling associating to treat patients with ankylosing spondylitis, effectively solves the impact of patient articular's pain, inflammatory factor.
Technical scheme of the present invention is: a kind of medicine for the treatment of ankylosing spondylitis, mainly comprises for oral administration, external two groups of medicines, wherein oral medicine composition: Semen Cuscutae 15g, fry Radix Dipsaci 15g, Cortex Eucommiae (parched) 10g, Radix Rehmanniae Preparata 10g, Fructus Corni 10g, Rhizoma Cibotii 15g, Herba Taxilli 15g, Radix Cyathulae 15g, Fructus Psoraleae 10g, Ramulus Cinnamomi 15g, Fructus Ligustri Lucidi 8g, Herba Ecliptae 8g, Radix Angelicae Sinensis 15g, Semen Persicae 15g, Radix Paeoniae Alba 30g, Radix Glycyrrhizae 6g.Every day 1 dose, be decocted in water for oral dose.External used medicine forms: Rhizoma Et Radix Notopterygii 15g, Ramulus Cinnamomi 15g, Caulis Sargentodoxae 15g, Herba Lycopodii 15g, Herba speranskiae tuberculatae 15g, Lignum Sappan 8g, Caulis Trachelospermi 10g, Semen Coicis 30g.Patient lies supine is on steaming bed, and get in top loading gauze medicated bag and put into full-automatic stifling dipping instrument, add water middle decoction, and by affected part just to stifling window, temperature keeps about 40 DEG C, every day 1 time, at every turn stifling half an hour.During treatment, for oral administration, stifling same use 1 month is 1 course for the treatment of, and two groups use 3 months all continuously.
Ankylosing spondylitis is a kind of chronic inflammatory disease rheumatic disease, belongs to Chinese medicine " numbness is sick " category, has again the title of " rheumatism involving the bone ", " severe hunch-back ", " ring wind ".Patient clinical is chief complaint mainly with waist sacrum back pain, arthralgia, joint joint stuffiness etc., thus joint pain alleviation, function of joint improvement be the primary aspect of clinical appraisal curative effect.Modern medicine study is thought, ankylosing spondylitis is the chronic inflammation disease that one kind of multiple factors participate in jointly, and definite pathogenesis is still indefinite, but closely related with factors such as heredity, Non-adhesion inhibition index, immunity, bacteriological infection.In recent years, the biological characteristics of inflammatory cytokine, its role and the relation between its pathogenesis and disease activity in the inflammatory process of autoimmune disease become the important target spot of clinical concern
[5].If TNF-α is one of cytokine produced the earliest in inflammatory process, body inflammatory reaction can cause its level in local joint and serum to raise, there is multiple inflammatory and immune response activity, the bone destruction in joint and the inflammatory damage of surrounding tissue can be participated in by approach such as inducible factor activation.IL-6 is the high expressing cell factor before a kind of fibrosis, falls ill closely related with inflammation, in recent years with its medicine being targeting to disease incidence mechanism illustrate and clinical treatment has most important theories meaning and using value.In treatment, combination of Chinese and Western medicine opinion tool has the advantage for the treatment of both the principal and secondary aspects of a disease, rapid-action, few side effects.The author's clinical findings patient is many with deficiency of the liver and kindey card, say in conjunction with " Plain Questions the most pure virginity will be discussed greatly " " sun in spring, cold multiple in more than, then lumbosacral pain, joint stuffiness, pain in stock shin foot knee joint " visible deficiency of both the liver and kidney for its morbidity originally.The traditional Chinese medical science has " waist is house of kidney ", " the kidney generating marrow and dominating bone ", " the main muscle of liver storing blood " theory, patient Duo Yin natural endowment is not enough, ferritic is weak, in addition take good care of oneself the day after tomorrow improper, cause body asthenia of essence and blood, causing bone becomes homeless foster, and liver body loses supports, so grain cervical carcinoma with cachexia, muscles and bones is delayed weak, and wind-cold damp pathogen is taken advantage of a weak point morbidity.Therefore the strong muscle of palpus kidney tonifying, expelling wind and removing dampness, the promoting blood circulation to remove obstruction in the collateral controlled.In conjunction with its pathogenic characteristic, the author selects external treatment in the traditional Chinese medical science to share and controls it.Chinese medicine for oral administration is authors'several years Empirical formula, focuses on kidney-boosting tonic.In side, Semen Cuscutae, stir-fry Radix Dipsaci, Cortex Eucommiae (parched) focus on kidney tonifying gas, have the merit of the strong muscle of kidney tonifying; Radix Rehmanniae Preparata, Fructus Corni, Fructus Ligustri Lucidi, Herba Ecliptae merit are filling up kidney essense, with bone marrow of supplementing nutrition; Rhizoma Cibotii is longer than the strong ridge of strong bone, the good medicine that main back is strong, wind is empty; Herba Taxilli is liver and kidney tonifying, dispel the wind, the good medicine of bone and muscle strengthening; Radix Cyathulae merit is at invigorating the liver and kidney, promoting blood circulation to restore menstrual flow, and invigorating middle warmer has row; Fructus Psoraleae focuses on the kidney warming sun, with Ramulus Cinnamomi match can expelling wind and removing dampness, nourishing kidney tonifying YANG, warming yang for activating qi-flowing; Chinese Angelica blood replonishing is invigorated blood circulation; Semen Persicae is longer than promoting blood circulation and breaking stagnation pain relieving; Radix Paeoniae Alba liver nourishing easing the affected liver, with Radix Glycyrrhizae compatibility relieving spasm to stop pain.Multiple medicines compatibility, to mend, be auxiliary to lead to, invigorating middle warmer has row, plays the effect of the strong muscle of kidney tonifying, promoting blood circulation and stopping pain altogether.In addition, herbal fumigation is the warm stimulation affected part skin opening of the pores utilizing medicine as external treatment, and drug effect is gone directly disease institute, has good absorbing, acts on the advantages such as direct, rapid-action.Moreover, medicament fumigating is beneficial to and promotes local affected part blood circulation, with easing joint movement, alleviates arthralgia, have " by table thoroughly in ", " inner disease outer treat ", " antiperspirant and do not hinder battalion defend " feature.Fumigation and wash method focuses on easing joint movement, promoting blood circulation to remove obstruction in the collateral, and medicine is based on nature and flavor bitter cold, and notopterygium wind dispelling dehumidifies, removing obstruction in the collateral to relieve pain; , there is the effect of supporing yang cold expelling, promoting the circulation of QI to relieve pain in Ramulus Cinnamomi energy promoting blood circulation joint; Caulis Sargentodoxae is longer than promoting blood circulation by removing wind, promoting the circulation of QI to relieve pain; Herba speranskiae tuberculatae, Herba Lycopodii merit can active relaxing muscles and tendons, damp-clearing pain-relievings; Lignum Sappan is longer than blood circulation promoting and blood stasis dispelling, removing obstruction in the collateral to relieve pain; Caulis Trachelospermi is invigorated blood circulation with the meridian dredging and is good at, and is specially in the good medicine of relaxing muscles and tendons and activating QI and blood in the collateral; Semen Coicis merit can heat clearing away eliminating impediment after spleen invigorating.Multiple medicines compatibility, plays expelling wind and removing dampness, the effect of eliminating impediment of invigorating blood circulation altogether.
The present invention treats the inside and outside associating of ankylosing spondylitis, treating both the principal and secondary aspects of a disease, especially treats deficiency of the liver and kindey card ankylosing spondylitis and has obvious efficiency.
Detailed description of the invention
Below in conjunction with embodiment, the invention will be further described.
Embodiment: a kind of medicine for the treatment of ankylosing spondylitis, mainly comprises for oral administration, external two groups of medicines, wherein oral medicine composition: Semen Cuscutae 15g, fry Radix Dipsaci 15g, Cortex Eucommiae (parched) 10g, Radix Rehmanniae Preparata 10g, Fructus Corni 10g, Rhizoma Cibotii 15g, Herba Taxilli 15g, Radix Cyathulae 15g, Fructus Psoraleae 10g, Ramulus Cinnamomi 15g, Fructus Ligustri Lucidi 8g, Herba Ecliptae 8g, Radix Angelicae Sinensis 15g, Semen Persicae 15g, Radix Paeoniae Alba 30g, Radix Glycyrrhizae 6g.Every day 1 dose, be decocted in water for oral dose.External used medicine forms: Rhizoma Et Radix Notopterygii 15g, Ramulus Cinnamomi 15g, Caulis Sargentodoxae 15g, Herba Lycopodii 15g, Herba speranskiae tuberculatae 15g, Lignum Sappan 8g, Caulis Trachelospermi 10g, Semen Coicis 30g.Patient lies supine is on steaming bed, and get in top loading gauze medicated bag and put into full-automatic stifling dipping instrument, add water middle decoction, and by affected part just to stifling window, temperature keeps about 40 DEG C, every day 1 time, at every turn stifling half an hour.During treatment, for oral administration, stifling same use 1 month is 1 course for the treatment of, and two groups use 3 months all continuously.
Clinical data
1, basic document.
Year November in January, 2013 to 2014 is routine in the patients with ankylosing spondylitis 74 that my institute is medical, be divided into matched group and each 37 examples of observation group patient at random.Matched group man 27 example, female 10 example; 24 ~ 45 years old age, year mean age (29.7 ± 2.5); The course of disease 5 months-13 years, average course of disease (5.8 ± 1.3) year; Observation group man 31 example, female 6 example; 23 ~ 43 years old age, year mean age (28.5 ± 2.4); The course of disease 6 months-11 years, average course of disease (5.4 ± 1.7) year; The physical data such as sex, age, the course of disease of two groups of patients is through statistical procedures, and no statistical difference difference (P>0.05), illustrates to have comparability between two groups.
2, diagnostic criteria.
Tcm diagnosis is made a definite diagnosis with reference to the diagnostic criteria of deficiency of the liver and kindey card ankylosing spondylitis relevant in " new Chinese medicine guideline of clinical investigations ".Patient clinical draws the ridge buttocks back of the body with lumbago, stiff deformity, wasting and atrophy of muscle, joint stuffiness, and hand is not warm, aversion to cold and preference for warmth, or soreness of the waist and knees, spermatorrhea, sexual impotence etc., pale tongue, tongue Bai Shaojin, deep and weak pulse or count accurately.
3, Therapeutic Method.
Matched group: give the match of Western medicine benefit general (the accurate word of traditional Chinese medicines: S20050058, enterprise: Shanghai CP Guojian Pharmaceutical Co., Ltd., specification: 12.5mg/ bottle) subcutaneous injection, each 25mg, 2 times weekly, every minor tick 3-4 days, dissolve with 1 milliliter of water for injection before injection, after dissolving, closed environment can in 2-8 DEG C of cold preservation 72 hours.
Observation group: to a kind of medicine therapeutic alliance for oral administration, stifling for the treatment of ankylosing spondylitis of the present invention.For oral administration: Semen Cuscutae 15g, fry Radix Dipsaci 15g, Cortex Eucommiae (parched) 10g, Radix Rehmanniae Preparata 10g, Fructus Corni 10g, Rhizoma Cibotii 15g, Herba Taxilli 15g, Radix Cyathulae 15g, Fructus Psoraleae 10g, Ramulus Cinnamomi 15g, Fructus Ligustri Lucidi 8g, Herba Ecliptae 8g, Radix Angelicae Sinensis 15g, Semen Persicae 15g, Radix Paeoniae Alba 30g, Radix Glycyrrhizae 6g.Every day 1 dose, be decocted in water for oral dose.2. stifling side is as follows: Rhizoma Et Radix Notopterygii 15g, Ramulus Cinnamomi 15g, Caulis Sargentodoxae 15g, Herba Lycopodii 15g, Herba speranskiae tuberculatae 15g, Lignum Sappan 8g, Caulis Trachelospermi 10g, Semen Coicis 30g.Patient lies supine is on steaming bed, and get in top loading gauze medicated bag and put into full-automatic stifling dipping instrument, add water middle decoction, and by affected part just to stifling window, temperature keeps about 40 DEG C, every day 1 time, at every turn stifling half an hour.
Within 1 month, be 1 course for the treatment of, treat observe the curative effect after 3 months all continuously for two groups.
4, therapeutic evaluation.
Recovery from illness: patients symptomatic disappears, joint, spinal function activity recover normal; Effective: symptom is obviously alleviated, joint, spinal function range of activity increase; Effective: symptom alleviates substantially, joint, spinal function range of activity have increased slightly; Invalid: symptom and joint, spinal function activity are unchanged.
5,
comparison of therapeutic.
the symptoms such as patient's back after treatment is stiff, joint stuffiness are obviously alleviated, and the effective percentage 70.3% of matched group, comparatively observation group's effective percentage 91.9% obviously reduces, and difference has statistical significance (P < 0.05).In table 1.
table 1 liang group patients with ankylosing spondylitis clinical efficacy contrast (example)
| Group | n | Cure | Effective | Effectively | Invalid | Effective percentage (%) |
| Matched group | 37 | 5 | 6 | 15 | 11 | 70.3 |
| Observation group | 37 | 13 | 11 | 10 | 3 | 91.9 a |
Conclusion: a kind of Chinese medicine composition therapeutic alliance ankylosing spondylitis Be very effective for oral administration, stifling for the treatment of ankylosing spondylitis of the present invention, is better than prior art.
Claims (1)
1. treat a medicine for ankylosing spondylitis, it is characterized in that, mainly comprise for oral administration, external two groups of medicines, wherein oral medicine composition: Semen Cuscutae 15g, fry Radix Dipsaci 15g, Cortex Eucommiae (parched) 10g, Radix Rehmanniae Preparata 10g, Fructus Corni 10g, Rhizoma Cibotii 15g, Herba Taxilli 15g, Radix Cyathulae 15g, Fructus Psoraleae 10g, Ramulus Cinnamomi 15g, Fructus Ligustri Lucidi 8g, Herba Ecliptae 8g, Radix Angelicae Sinensis 15g, Semen Persicae 15g, Radix Paeoniae Alba 30g, Radix Glycyrrhizae 6g; External used medicine forms: Rhizoma Et Radix Notopterygii 15g, Ramulus Cinnamomi 15g, Caulis Sargentodoxae 15g, Herba Lycopodii 15g, Herba speranskiae tuberculatae 15g, Lignum Sappan 8g, Caulis Trachelospermi 10g, Semen Coicis 30g; Patient lies supine is on steaming bed, and get in above-mentioned external used medicine loading gauze medicated bag and put into full-automatic stifling dipping instrument, add water middle decoction, and by affected part just to stifling window, temperature keeps about 40 DEG C, every day 1 time, at every turn stifling half an hour.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510286495.3A CN104840599B (en) | 2015-05-30 | 2015-05-30 | A kind of medicine for treating ankylosing spondylitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510286495.3A CN104840599B (en) | 2015-05-30 | 2015-05-30 | A kind of medicine for treating ankylosing spondylitis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104840599A true CN104840599A (en) | 2015-08-19 |
| CN104840599B CN104840599B (en) | 2018-03-27 |
Family
ID=53840845
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510286495.3A Expired - Fee Related CN104840599B (en) | 2015-05-30 | 2015-05-30 | A kind of medicine for treating ankylosing spondylitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104840599B (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105663662A (en) * | 2016-03-29 | 2016-06-15 | 广州三得医疗科技有限公司 | Traditional Chinese medicine composition containing folium artemisiae argyi and used for treating ankylosing spondylitis |
| CN108403843A (en) * | 2018-05-15 | 2018-08-17 | 郭志良 | A kind of Chinese medicine of strong backbone |
| CN109303832A (en) * | 2018-09-28 | 2019-02-05 | 刘安民 | A kind of Chinese medicine and preparation method thereof for treating ankylosing spondylitis |
| US11090365B2 (en) * | 2019-08-08 | 2021-08-17 | SVK Herbal Corporation | Composition and methods for treating bone and joint disease including extract from crocodilos reptilia and herbs |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104161937A (en) * | 2013-05-19 | 2014-11-26 | 陈洪波 | Traditional Chinese medicine preparation for treating lumbar muscle strain |
-
2015
- 2015-05-30 CN CN201510286495.3A patent/CN104840599B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104161937A (en) * | 2013-05-19 | 2014-11-26 | 陈洪波 | Traditional Chinese medicine preparation for treating lumbar muscle strain |
Non-Patent Citations (2)
| Title |
|---|
| 李含文: "《实用软组织伤病学》", 30 September 2014, 人民体育出版社 * |
| 李彦华等: "自拟强腰固肾汤治疗强直性脊柱炎40例", 《实用中医内科杂志》 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105663662A (en) * | 2016-03-29 | 2016-06-15 | 广州三得医疗科技有限公司 | Traditional Chinese medicine composition containing folium artemisiae argyi and used for treating ankylosing spondylitis |
| CN108403843A (en) * | 2018-05-15 | 2018-08-17 | 郭志良 | A kind of Chinese medicine of strong backbone |
| CN109303832A (en) * | 2018-09-28 | 2019-02-05 | 刘安民 | A kind of Chinese medicine and preparation method thereof for treating ankylosing spondylitis |
| US11090365B2 (en) * | 2019-08-08 | 2021-08-17 | SVK Herbal Corporation | Composition and methods for treating bone and joint disease including extract from crocodilos reptilia and herbs |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104840599B (en) | 2018-03-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102488869B (en) | Traditional Chinese medicinal external-use liniment for muscle and bone ache | |
| CN107158297B (en) | A kind of traditional Chinese medicine ointment for treating orthopedic pain and preparation method thereof | |
| CN102600264B (en) | Externally-applied traditional Chinese medical composition for treatment of orthopedic diseases | |
| CN103893702A (en) | Traditional Chinese medicine composition for treating cervical spine bone hyperplasia and preparation method thereof | |
| CN104840599A (en) | Medicine for treating ankylosing spondylitis | |
| CN103520579A (en) | Medicinal liquor used for treating lumbocrural pain, hyperostosis and sciatica | |
| CN102626505B (en) | Massaging paste based on Chinese medicinal herbs and preparation method thereof | |
| CN103495055A (en) | Traditional Chinese medicine decoction for treating female endocrine disorders and preparation method thereof | |
| CN104587252A (en) | Traditional Chinese medicine composition for treating kidney stones | |
| CN104043010A (en) | Traditional Chinese medicine (TCM) composition for treating prostatitis | |
| CN103860676B (en) | A kind of Chinese medicine for external application for the treatment of lumbar muscle strain and preparation method thereof | |
| CN104758525A (en) | Traditional Chinese medicine composition for treating primary dysmenorrhea in the type of cold-dampness coagulation | |
| CN105999119A (en) | Traditional Chinese medicinal formula for treating infertility and preparation method of traditional Chinese medicinal formula | |
| CN105535682A (en) | External-application traditional Chinese medicine for treating traumatic synovitis of knee joint and preparation method | |
| CN104173934A (en) | Traditional Chinese medicine composition for treating sciatica | |
| CN104740003A (en) | Traditional Chinese medicine for treating lumbar disc herniation | |
| CN103751454A (en) | Traditional Chinese medicine for treating rheumatism | |
| CN103356797A (en) | Chinese medicine composition for treating kidney stone | |
| CN102028810B (en) | Traditional Chinese medicine for treating lumbar intervertebral disc protrusion | |
| CN105748754A (en) | Traditional Chinese medicine composition for treating uterine prolapse | |
| CN104173930A (en) | Traditional Chinese medicine composition for treating cold-damp lumbago | |
| CN103705901A (en) | Traditional Chinese medicine composition for treating necrospermia | |
| CN105412378A (en) | Traditional Chinese medicine composition for treating hyperostosis and cervical spondylosis | |
| CN105687865A (en) | Traditional Chinese medicine composition for treating stranguria | |
| CN104147541A (en) | Health-care medicinal wine for treating osteoproliferation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| EXSB | Decision made by sipo to initiate substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180327 |